EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Targeted Screening for Congenital Cytomegalovirus in the Newborn Hearing Screening Program: A Population‐Based Cohort Study

Luana Uchoa Karvig, Emilie Luppescu Pedersen iD, Karina Jordan, Lisbeth Samsø Schmidt, Lærke Vinge Larsen iD, Anja Poulsen, Michael Bille, Emma Malchau Carlsen, Birgitte Smith, Bo Mølholm Hansen iD, Kirsten Fenger Hvilsted, Janko Moritz und 8 weitere

Acta Paediatrica · 2026

DOI: 10.1111/apa.70326 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Paediatrica, 2026. Verfasst von Luana Uchoa Karvig und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Neonatal Screening, Hearing Loss, Sensorineural. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Næstved, Slagelse and Ringsted Hospitals Research Fond, Capital Region of Denmark's Research Fond, Helsefonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To diagnose newborn infants with congenital cytomegalovirus (cCMV) related sensorineural hearing loss (SNHL) within the critical four‐week window for initiating antiviral treatment, we aimed to determine the number needed to test (NNT) for cCMV among newborn infants failing the neonatal hearing screening.

Method

A population‐based multicenter cohort study included newborn infants in East Denmark who failed two hearing screening tests and underwent saliva CMV screening between November 2021 and May 2024. The NNT was calculated as the inverse of the absolute detection rate of cCMV‐related SNHL in this cohort.

Results

A total of 484 infants with hearing screening failure were tested for cCMV. Of these, 27 (5.6%) were CMV positive in saliva and 7 (1.5%) were confirmed to have cCMV in urine, blood, or dried blood spots. Six (85.7%) of 7 infants with cCMV and initial hearing screening failure had normal hearing at follow‐up, leaving 1 (0.2%) of 484 with cCMV‐related SNHL and an NNT of 484 (95% CI 87‐20 000).

Conclusion

In our setting, targeted screening for cCMV resulted in a high NNT of almost 500 to identify one newborn infant with cCMV‐related SNHL, reflecting a low incidence of cCMV‐related SNHL and a high risk of false‐positive hearing screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsNeonatal ScreeningHearing Loss, SensorineuralHumansInfant, NewbornMaleHearing TestsFemaleCohort StudiesDenmark

Autor:innen und Institutionen

  • Department of Paediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Paediatrics and Adolescent Medicine, Slagelse Hospital, Slagelse, Denmark.
  • Department of Paediatrics and Adolescent Medicine, Herlev Hospital, Herlev, Denmark.
  • Department of Clinical Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Otorhinolaryngology Head and Neck Surgery and Audiology, Copenhagen Hearing and Balance Center, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Paediatrics and Adolescent Medicine, Hvidovre Hospital, Hvidovre, Denmark.

ORCID-Profile: Emilie Luppescu Pedersen, Lærke Vinge Larsen, Bo Mølholm Hansen, Stine Lund

Förderung

  • Næstved, Slagelse and Ringsted Hospitals Research Fond
  • Capital Region of Denmark's Research Fond
  • Helsefonden

Zitieren

APA

Karvig, L. U., Pedersen, E. L., Jordan, K., Schmidt, L. S., Larsen, L. V., Poulsen, A., Bille, M., Carlsen, E. M., Smith, B., Hansen, B. M., Hvilsted, K. F., Moritz, J., Jensen, L. H., Stanchev, H., Nielsen, X. C., Zaharova, T., Vestergaard, D., Rytter, M. J. H., Nygaard, U., & Lund, S. (2026). Targeted Screening for Congenital Cytomegalovirus in the Newborn Hearing Screening Program: A Population‐Based Cohort Study. Acta Paediatrica. https://doi.org/10.1111/apa.70326

Vancouver

Karvig LU, Pedersen EL, Jordan K, Schmidt LS, Larsen LV, Poulsen A, et al. Targeted Screening for Congenital Cytomegalovirus in the Newborn Hearing Screening Program: A Population‐Based Cohort Study. Acta Paediatrica. 2026. doi:10.1111/apa.70326

BibTeX
@article{Karvig2026,
  author = {Karvig, Luana Uchoa and Pedersen, Emilie Luppescu and Jordan, Karina and Schmidt, Lisbeth Samsø and Larsen, Lærke Vinge and Poulsen, Anja and Bille, Michael and Carlsen, Emma Malchau and Smith, Birgitte and Hansen, Bo Mølholm and Hvilsted, Kirsten Fenger and Moritz, Janko and Jensen, Lise Heilmann and Stanchev, Hristo and Nielsen, Xiaohui Chen and Zaharova, Tatjana and Vestergaard, Dorthe and Rytter, Maren Johanne Heilskov and Nygaard, Ulrikka and Lund, Stine},
  title = {Targeted Screening for Congenital Cytomegalovirus in the Newborn Hearing Screening Program: A Population‐Based Cohort Study},
  journal = {Acta Paediatrica},
  year = {2026},
  doi = {10.1111/apa.70326}
}
Kostenlos starten →